Frederick Chi-Shing Wang, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphocryptovirus | 9 | 2006 | 14 | 1.700 |
Why?
|
| Herpesviridae Infections | 7 | 2006 | 268 | 1.010 |
Why?
|
| Herpesvirus 4, Human | 13 | 2017 | 1080 | 0.930 |
Why?
|
| Macaca mulatta | 9 | 2013 | 2341 | 0.690 |
Why?
|
| Oculomotor Muscles | 4 | 2015 | 405 | 0.600 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 5 | 2007 | 158 | 0.590 |
Why?
|
| Tumor Virus Infections | 5 | 2006 | 438 | 0.550 |
Why?
|
| Genome, Viral | 4 | 2006 | 674 | 0.510 |
Why?
|
| Retinal Pigments | 1 | 2015 | 84 | 0.500 |
Why?
|
| Epstein-Barr Virus Infections | 5 | 2013 | 617 | 0.500 |
Why?
|
| Color Vision | 1 | 2015 | 23 | 0.490 |
Why?
|
| Color | 1 | 2015 | 297 | 0.450 |
Why?
|
| Mydriatics | 1 | 2013 | 67 | 0.440 |
Why?
|
| Accommodation, Ocular | 1 | 2013 | 47 | 0.440 |
Why?
|
| Exotropia | 2 | 2006 | 64 | 0.430 |
Why?
|
| Atropine | 1 | 2013 | 243 | 0.430 |
Why?
|
| Pupil | 1 | 2013 | 147 | 0.410 |
Why?
|
| Horner Syndrome | 1 | 2012 | 35 | 0.400 |
Why?
|
| Iris Diseases | 1 | 2012 | 36 | 0.390 |
Why?
|
| Pigmentation Disorders | 1 | 2012 | 105 | 0.380 |
Why?
|
| Light | 1 | 2015 | 1358 | 0.320 |
Why?
|
| Esotropia | 2 | 2015 | 99 | 0.320 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2017 | 1802 | 0.310 |
Why?
|
| Nasopharyngeal Neoplasms | 2 | 2017 | 289 | 0.310 |
Why?
|
| Ophthalmologic Surgical Procedures | 3 | 2015 | 354 | 0.300 |
Why?
|
| Open Reading Frames | 3 | 2006 | 818 | 0.280 |
Why?
|
| Callithrix | 2 | 2005 | 95 | 0.260 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2004 | 543 | 0.250 |
Why?
|
| Cell Transformation, Viral | 3 | 2006 | 527 | 0.240 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 1466 | 0.230 |
Why?
|
| Cytomegalovirus | 2 | 2006 | 754 | 0.230 |
Why?
|
| B-Lymphocytes | 5 | 2006 | 4787 | 0.210 |
Why?
|
| Postoperative Care | 1 | 2009 | 1480 | 0.200 |
Why?
|
| Disease Models, Animal | 4 | 2013 | 18329 | 0.200 |
Why?
|
| Immunocompromised Host | 2 | 2004 | 865 | 0.190 |
Why?
|
| Nystagmus, Pathologic | 1 | 2002 | 104 | 0.180 |
Why?
|
| Epitopes, T-Lymphocyte | 5 | 2007 | 827 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2007 | 4652 | 0.170 |
Why?
|
| Antibodies, Viral | 3 | 2005 | 3213 | 0.160 |
Why?
|
| Vision, Binocular | 3 | 2015 | 225 | 0.140 |
Why?
|
| Pupil Disorders | 2 | 2013 | 33 | 0.130 |
Why?
|
| Chlorophyll | 1 | 2015 | 30 | 0.130 |
Why?
|
| Abducens Nerve Diseases | 1 | 2015 | 44 | 0.120 |
Why?
|
| Molecular Sequence Data | 7 | 2006 | 17609 | 0.120 |
Why?
|
| Cell Line, Transformed | 4 | 2007 | 861 | 0.120 |
Why?
|
| Amino Acid Sequence | 6 | 2006 | 13411 | 0.110 |
Why?
|
| Mydriasis | 1 | 2013 | 13 | 0.110 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2015 | 183 | 0.110 |
Why?
|
| Viral Proteins | 4 | 2007 | 1801 | 0.110 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 1206 | 0.100 |
Why?
|
| Antigens, Viral | 3 | 2007 | 995 | 0.100 |
Why?
|
| Eye Color | 1 | 2012 | 35 | 0.100 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2017 | 1503 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2004 | 3698 | 0.100 |
Why?
|
| Iridocorneal Endothelial Syndrome | 1 | 2011 | 1 | 0.100 |
Why?
|
| Maximum Tolerated Dose | 1 | 2013 | 896 | 0.090 |
Why?
|
| Myopia | 1 | 2013 | 254 | 0.090 |
Why?
|
| Virus Latency | 2 | 2005 | 359 | 0.090 |
Why?
|
| Base Sequence | 4 | 2006 | 12415 | 0.080 |
Why?
|
| Animals | 15 | 2015 | 168939 | 0.080 |
Why?
|
| Strabismus | 1 | 2013 | 320 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 1998 | 3401 | 0.080 |
Why?
|
| DNA, Viral | 3 | 2004 | 2201 | 0.070 |
Why?
|
| Antigen Presentation | 2 | 2007 | 1250 | 0.070 |
Why?
|
| Rhadinovirus | 1 | 2006 | 37 | 0.060 |
Why?
|
| Carcinoma | 1 | 2017 | 2325 | 0.060 |
Why?
|
| Amygdala | 1 | 2013 | 1375 | 0.060 |
Why?
|
| Herpesvirus 8, Human | 1 | 2007 | 254 | 0.060 |
Why?
|
| T-Cell Antigen Receptor Specificity | 1 | 2005 | 89 | 0.060 |
Why?
|
| Palatine Tonsil | 1 | 2005 | 193 | 0.060 |
Why?
|
| Visual Perception | 1 | 2013 | 1392 | 0.060 |
Why?
|
| Immunodominant Epitopes | 1 | 2005 | 244 | 0.060 |
Why?
|
| Leukoplakia, Hairy | 1 | 2004 | 10 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 2561 | 0.060 |
Why?
|
| Immunocompetence | 1 | 2004 | 138 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2005 | 404 | 0.060 |
Why?
|
| Cell Line | 4 | 2007 | 15564 | 0.050 |
Why?
|
| Serologic Tests | 1 | 2005 | 382 | 0.050 |
Why?
|
| Alanine | 1 | 2005 | 613 | 0.050 |
Why?
|
| Replication Origin | 1 | 2002 | 77 | 0.050 |
Why?
|
| Monkey Diseases | 1 | 2002 | 71 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2007 | 2746 | 0.050 |
Why?
|
| Immunologic Memory | 2 | 2007 | 1377 | 0.050 |
Why?
|
| Capsid Proteins | 1 | 2005 | 468 | 0.050 |
Why?
|
| Glycine | 1 | 2005 | 670 | 0.050 |
Why?
|
| Diplopia | 2 | 2015 | 217 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2005 | 4410 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2002 | 197 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2002 | 1057 | 0.050 |
Why?
|
| Glaucoma | 1 | 2011 | 1194 | 0.050 |
Why?
|
| Papio | 1 | 2003 | 672 | 0.050 |
Why?
|
| Species Specificity | 1 | 2005 | 2413 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2005 | 2177 | 0.050 |
Why?
|
| Viremia | 1 | 2004 | 727 | 0.050 |
Why?
|
| Integrins | 1 | 2005 | 839 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4356 | 0.050 |
Why?
|
| RNA, Viral | 3 | 2004 | 2867 | 0.050 |
Why?
|
| Cell Culture Techniques | 2 | 2006 | 1646 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2007 | 1560 | 0.050 |
Why?
|
| Haplorhini | 1 | 2001 | 520 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2006 | 1362 | 0.040 |
Why?
|
| Genes, Viral | 1 | 2001 | 654 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2003 | 1159 | 0.040 |
Why?
|
| Humans | 19 | 2017 | 766812 | 0.040 |
Why?
|
| Point Mutation | 1 | 2005 | 1592 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2002 | 15831 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2004 | 1968 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2005 | 1442 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 9407 | 0.040 |
Why?
|
| Infant | 2 | 2012 | 36459 | 0.040 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2002 | 527 | 0.040 |
Why?
|
| Eye Movements | 1 | 2002 | 510 | 0.040 |
Why?
|
| T-Lymphocytes | 2 | 2007 | 10263 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2002 | 903 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2004 | 2586 | 0.040 |
Why?
|
| Viral Load | 2 | 2004 | 3385 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2005 | 2669 | 0.040 |
Why?
|
| HIV Antigens | 1 | 1998 | 328 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 12985 | 0.030 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2017 | 126 | 0.030 |
Why?
|
| Cytomegalovirus Infections | 1 | 2003 | 838 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2006 | 2856 | 0.030 |
Why?
|
| Lymphoma, B-Cell | 1 | 2002 | 945 | 0.030 |
Why?
|
| Lymphoma | 1 | 2004 | 1899 | 0.030 |
Why?
|
| Sensory Deprivation | 1 | 2015 | 109 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2002 | 1893 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1998 | 1156 | 0.030 |
Why?
|
| Eyeglasses | 1 | 2015 | 138 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1998 | 923 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1998 | 1524 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 13489 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 26387 | 0.020 |
Why?
|
| Male | 6 | 2017 | 364154 | 0.020 |
Why?
|
| DNA-Binding Proteins | 2 | 2006 | 9613 | 0.020 |
Why?
|
| Reoperation | 1 | 2002 | 4325 | 0.020 |
Why?
|
| Gonioscopy | 1 | 2011 | 157 | 0.020 |
Why?
|
| Child | 2 | 2013 | 80670 | 0.020 |
Why?
|
| Scotoma | 1 | 2011 | 128 | 0.020 |
Why?
|
| Trabeculectomy | 1 | 2011 | 174 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 42577 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2005 | 10451 | 0.020 |
Why?
|
| Visual Field Tests | 1 | 2011 | 415 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2006 | 65286 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 5795 | 0.020 |
Why?
|
| Adolescent | 2 | 2013 | 88902 | 0.020 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2007 | 91 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2002 | 4278 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2013 | 1989 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6853 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2017 | 5890 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4892 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2011 | 1652 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5306 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 36570 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2011 | 1304 | 0.020 |
Why?
|
| Dipeptides | 1 | 2007 | 386 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2017 | 8728 | 0.010 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2003 | 133 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2007 | 1494 | 0.010 |
Why?
|
| RNA, Nuclear | 1 | 2002 | 29 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2007 | 1867 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2006 | 1525 | 0.010 |
Why?
|
| Viral Matrix Proteins | 1 | 2003 | 193 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2011 | 2714 | 0.010 |
Why?
|
| Virus Activation | 1 | 2003 | 322 | 0.010 |
Why?
|
| Female | 3 | 2017 | 396532 | 0.010 |
Why?
|
| Cadherins | 1 | 2005 | 903 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 2062 | 0.010 |
Why?
|
| Hippocampus | 1 | 2013 | 3776 | 0.010 |
Why?
|
| Epitopes | 1 | 2007 | 2526 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 11062 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 2002 | 908 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2510 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13642 | 0.010 |
Why?
|
| Haplotypes | 1 | 2006 | 2726 | 0.010 |
Why?
|
| Ligands | 1 | 2005 | 3274 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 5022 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 1892 | 0.010 |
Why?
|
| Virus Replication | 1 | 2006 | 2457 | 0.010 |
Why?
|
| Simian immunodeficiency virus | 1 | 2003 | 812 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2006 | 2875 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6507 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2006 | 4166 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 171344 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 4780 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2003 | 5795 | 0.010 |
Why?
|
| Middle Aged | 2 | 2017 | 223267 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 3468 | 0.010 |
Why?
|
| Adult | 2 | 2017 | 223305 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2006 | 18986 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 59939 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7612 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 54872 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 11924 | 0.000 |
Why?
|
| Time Factors | 1 | 2006 | 40149 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2003 | 12159 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2002 | 39312 | 0.000 |
Why?
|